Market Cap 37.30M
Revenue (ttm) 2.27M
Net Income (ttm) -59.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,625.55%
Debt to Equity Ratio -1.01
Volume 784,000
Avg Vol 3,752,058
Day's Range N/A - N/A
Shares Out 16.01M
Stochastic %K 32%
Beta 0.18
Analysts Sell
Price Target $8.25

Company Profile

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally...

Industry: Biotechnology
Sector: Healthcare
Phone: 475 238 6837
Address:
555 Long Wharf Drive, 12th Floor, New Haven, United States
tommy45
tommy45 Oct. 27 at 1:55 PM
$BTAI very possible to see 2.90 or so this week. oversold and there so much good news in the pipe line. down the road this a 10 plus dollar stock gl
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 27 at 11:19 AM
Enter: $BTAI Calls Strike Price: $2 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $3.50 Sell Price: $0.11 Profit : +114% (Turn every $1 into $2.14) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
tommy45
tommy45 Oct. 27 at 11:12 AM
$BTAI should head back to around 3 gl
0 · Reply
Zappiys
Zappiys Oct. 26 at 10:58 PM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 26 at 3:37 PM
Enter: $BTAI Calls Strike Price: $2 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $3.50 Sell Price: $0.11 Profit : +114% (Turn every $1 into $2.14) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
SrTxan
SrTxan Oct. 26 at 12:07 PM
$BTAI A new fund has purchased BTAI. It is SLT HOLDINGS LLC, which acquired 29,500 shares at an average price of $2.56. Tomorrow, official sources will also report that short investors have reduced their position in BTAI by 28.24%. Short interest currently stands at 1,141,061 shares (approximately 450,000 fewer shares shorted).
4 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 26 at 10:30 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BTAI Current Share Price: $2.33 Contracts: $BTAI January 16, 2026 $2 Calls Scale in: $0.81- $0.99 Scale out: $1.26-$1.62 Can Easily Capture: 60% ROI Blended DTE: 82 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 8:47 PM
Enter: $BTAI Calls Strike Price: $2 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $3.50 Sell Price: $0.11 Profit : +114% (Turn every $1 into $2.14) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
BayAreaBiotech
BayAreaBiotech Oct. 25 at 5:24 PM
$BTAI BTAI has publicly indicated intent to start TRANQUILITY In-Care soon after the At-Home results and has been evaluating CROs to operationalize the trial. It hasn’t publicly announced “first patient dosed” or posted a new Phase 3 In-Care start on http://ClinicalTrials.gov yet. Starting this trial will be a great step forward and positive results will be a game changer for Alzheimer’s and dementia patients. One report estimates the global Alzheimer’s agitation treatment market at ~ US$4.5 billion in 2024, and projects growth to around US$8.2 billion by 2033 (CAGR ~8 %) for that specific indication. Canaccord Conference (Aug 12, 2025): “We have a protocol that [FDA] agreed on, ready to go… selecting a CRO… triggering the trial will be the next steps… basically ready to go very soon.” HC Wainwright Conference (Sep 8, 2025): They had “agreement… for the Alzheimer’s program,” with CRO evaluations underway to initiate the trial.
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 25 at 12:54 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BTAI Current Share Price: $2.33 Contracts: $BTAI January 16, 2026 $2 Calls Scale in: $0.81- $0.99 Scale out: $1.26-$1.62 Can Easily Capture: 60% ROI Blended DTE: 83 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Latest News on BTAI
BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment

Aug 27, 2025, 12:01 PM EDT - 2 months ago

BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment


BioXcel's agitation drug meets main goal in at-home study

Aug 27, 2025, 7:29 AM EDT - 2 months ago

BioXcel's agitation drug meets main goal in at-home study


BioXcel Therapeutics Announces Reverse Stock Split

Feb 6, 2025, 7:00 AM EST - 9 months ago

BioXcel Therapeutics Announces Reverse Stock Split


BioXcel Therapeutics Announces Proposed Public Offering

Nov 21, 2024, 4:47 PM EST - 1 year ago

BioXcel Therapeutics Announces Proposed Public Offering


BioXcel Therapeutics to Present at ThinkEquity Conference

Oct 29, 2024, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics to Present at ThinkEquity Conference


tommy45
tommy45 Oct. 27 at 1:55 PM
$BTAI very possible to see 2.90 or so this week. oversold and there so much good news in the pipe line. down the road this a 10 plus dollar stock gl
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 27 at 11:19 AM
Enter: $BTAI Calls Strike Price: $2 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $3.50 Sell Price: $0.11 Profit : +114% (Turn every $1 into $2.14) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
tommy45
tommy45 Oct. 27 at 11:12 AM
$BTAI should head back to around 3 gl
0 · Reply
Zappiys
Zappiys Oct. 26 at 10:58 PM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 26 at 3:37 PM
Enter: $BTAI Calls Strike Price: $2 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $3.50 Sell Price: $0.11 Profit : +114% (Turn every $1 into $2.14) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
SrTxan
SrTxan Oct. 26 at 12:07 PM
$BTAI A new fund has purchased BTAI. It is SLT HOLDINGS LLC, which acquired 29,500 shares at an average price of $2.56. Tomorrow, official sources will also report that short investors have reduced their position in BTAI by 28.24%. Short interest currently stands at 1,141,061 shares (approximately 450,000 fewer shares shorted).
4 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 26 at 10:30 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BTAI Current Share Price: $2.33 Contracts: $BTAI January 16, 2026 $2 Calls Scale in: $0.81- $0.99 Scale out: $1.26-$1.62 Can Easily Capture: 60% ROI Blended DTE: 82 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 8:47 PM
Enter: $BTAI Calls Strike Price: $2 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $3.50 Sell Price: $0.11 Profit : +114% (Turn every $1 into $2.14) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
BayAreaBiotech
BayAreaBiotech Oct. 25 at 5:24 PM
$BTAI BTAI has publicly indicated intent to start TRANQUILITY In-Care soon after the At-Home results and has been evaluating CROs to operationalize the trial. It hasn’t publicly announced “first patient dosed” or posted a new Phase 3 In-Care start on http://ClinicalTrials.gov yet. Starting this trial will be a great step forward and positive results will be a game changer for Alzheimer’s and dementia patients. One report estimates the global Alzheimer’s agitation treatment market at ~ US$4.5 billion in 2024, and projects growth to around US$8.2 billion by 2033 (CAGR ~8 %) for that specific indication. Canaccord Conference (Aug 12, 2025): “We have a protocol that [FDA] agreed on, ready to go… selecting a CRO… triggering the trial will be the next steps… basically ready to go very soon.” HC Wainwright Conference (Sep 8, 2025): They had “agreement… for the Alzheimer’s program,” with CRO evaluations underway to initiate the trial.
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 25 at 12:54 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BTAI Current Share Price: $2.33 Contracts: $BTAI January 16, 2026 $2 Calls Scale in: $0.81- $0.99 Scale out: $1.26-$1.62 Can Easily Capture: 60% ROI Blended DTE: 83 Days | Join Elites here: https://liquidtheta.com
0 · Reply
mtc2223
mtc2223 Oct. 25 at 12:22 PM
$BTAI https://www.businesswire.com/news/home/20251024064855/en/
2 · Reply
Bob584
Bob584 Oct. 24 at 8:24 PM
$BTAI 6,500 of my 16,875 shares out on loan came back in yesterday. Now we just need the Institutions to reverse course. I'd also be happy with a partnership or buyout announcement.
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 6:53 PM
Enter: $BTAI JAN 16 2026 $2 CALLS Buy in Price: $0.05 - $3.50 Take Profit: $0.07 Stop Bleeding: $0.04 ROI Potential: 37% https://moneygroup.us/
0 · Reply
Kewlpapa
Kewlpapa Oct. 24 at 6:47 PM
$BTAI the 1 bear with multiple accounts will soon get tired here. Too many catalyst coming up. I hate to see anyone lose money.
0 · Reply
MakeM0ney_444
MakeM0ney_444 Oct. 24 at 6:23 PM
$BTAI watch now the ceo be like “oh stonk go up, we don’t have to say anything now” Fucking. Disaster
0 · Reply
Mpd16
Mpd16 Oct. 24 at 6:13 PM
$BTAI block the noise.
0 · Reply
Rvazstocksfl
Rvazstocksfl Oct. 24 at 5:43 PM
$BTAI why scam is up
2 · Reply
Djdanny
Djdanny Oct. 24 at 5:37 PM
$BTAI any chance for $4 this year .
0 · Reply
Mg_1970
Mg_1970 Oct. 24 at 5:21 PM
$BTAI The same fucked positions...How much time wasted here 😱😱🤦‍♂️😭
0 · Reply
Mg_1970
Mg_1970 Oct. 24 at 5:11 PM
$BTAI There is no reason 🙄🤞 I'm loosing here
0 · Reply
Mg_1970
Mg_1970 Oct. 24 at 5:04 PM
$BTAI Cash Position The company has 22.3 months of cash left based on quarterly cash burn of -$6.31M and estimated current cash of $46.8M
0 · Reply
Rvazstocksfl
Rvazstocksfl Oct. 24 at 5:03 PM
$BTAI why this scammer is up
1 · Reply